Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangyi Meng

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
Nature Communications|June 29, 2026
Unifying network connectivity from geodesics to random walks via the random cluster modelXiangyi Meng, Chenxuguang Zhu, Nicola Pedreschi, et al.
American Journal of Alzheimer'S Disease and Other Dementias|March 19, 2009
Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's diseaseCarl H Sadowsky, Alan Dengiz, Jason T Olin, et al.
Frontiers in Oncology|December 17, 2024
Intramedullary schwannoma of conus medullaris with syringomyelia: a case report and literature reviewHua Guo, Yao Wang, Liankun Wang, et al.
Entropy (Basel, Switzerland)|November 24, 2023
Percolation Theories for Quantum NetworksXiangyi Meng, Xinqi Hu, Yu Tian, et al.
Journal of Hazardous Materials|April 1, 2022
CRISPR-Cas12a-mediated luminescence resonance energy transfer aptasensing platform for deoxynivalenol using gold nanoparticle-decorated Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene as the enhanced quencherXianfeng Lin, Changxin Li, Xiangyi Meng, et al.
Pathology, Research and Practice|October 26, 2024
METTL3-induced lncARSR aggravates neuroblastoma tumorigenic properties through stabilizing PHOX2BXiangyi Meng, Zhu Tan, Bihua Qiu, et al.
Dementia and Geriatric Cognitive Disorders Extra|November 1, 2013
Comparing clinical profiles in Alzheimer's disease and Parkinson's disease dementiaMartin R Farlow, Frederick Schmitt, Dag Aarsland, et al.
Dementia and Geriatric Cognitive Disorders|May 27, 2010
Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysisJeffrey L Cummings, Steven H Ferris, Martin R Farlow, et al.
Multiple Sclerosis and Related Disorders|July 24, 2018
Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 studyMark Cascione, Nadia Tenenbaum, Jeanette Wendt, et al.
Alzheimer Disease and Associated Disorders|December 2, 2014
A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer DiseaseMartin R Farlow, George T Grossberg, Carl H Sadowsky, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Nature Communications|June 29, 2026
Unifying network connectivity from geodesics to random walks via the random cluster modelXiangyi Meng, Chenxuguang Zhu, Nicola Pedreschi, et al.
American Journal of Alzheimer'S Disease and Other Dementias|March 19, 2009
Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's diseaseCarl H Sadowsky, Alan Dengiz, Jason T Olin, et al.
Frontiers in Oncology|December 17, 2024
Intramedullary schwannoma of conus medullaris with syringomyelia: a case report and literature reviewHua Guo, Yao Wang, Liankun Wang, et al.
Entropy (Basel, Switzerland)|November 24, 2023
Percolation Theories for Quantum NetworksXiangyi Meng, Xinqi Hu, Yu Tian, et al.
Journal of Hazardous Materials|April 1, 2022
CRISPR-Cas12a-mediated luminescence resonance energy transfer aptasensing platform for deoxynivalenol using gold nanoparticle-decorated Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene as the enhanced quencherXianfeng Lin, Changxin Li, Xiangyi Meng, et al.
Pathology, Research and Practice|October 26, 2024
METTL3-induced lncARSR aggravates neuroblastoma tumorigenic properties through stabilizing PHOX2BXiangyi Meng, Zhu Tan, Bihua Qiu, et al.
Dementia and Geriatric Cognitive Disorders Extra|November 1, 2013
Comparing clinical profiles in Alzheimer's disease and Parkinson's disease dementiaMartin R Farlow, Frederick Schmitt, Dag Aarsland, et al.
Dementia and Geriatric Cognitive Disorders|May 27, 2010
Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysisJeffrey L Cummings, Steven H Ferris, Martin R Farlow, et al.
Multiple Sclerosis and Related Disorders|July 24, 2018
Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 studyMark Cascione, Nadia Tenenbaum, Jeanette Wendt, et al.
Alzheimer Disease and Associated Disorders|December 2, 2014
A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer DiseaseMartin R Farlow, George T Grossberg, Carl H Sadowsky, et al.
Pageof 14